Aragen secures $100 million investment from Quadria Capital
Investment will fund expansion to meet rising demand for CRDMO services
Investment will fund expansion to meet rising demand for CRDMO services
Acquisition expands high-value medical platform
The biosimilar Ustekinumab has been developed and manufactured by the company
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies
Aromatic L-amino acid decarboxylase deficiency is a rare genetic disorder that affects the production of some neurotransmitters
This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
Subscribe To Our Newsletter & Stay Updated